Carlos Vila Silván

Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial

Sven G. Meuth, T. Henze, Ute Essner et al. · International Journal of Neuroscience · 2020 · 26 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

A real‐world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described ‘spasticity‐plus syndrome’

Francesco Patti, Clara Grazia Chisari, Óscar Fernández et al. · European Journal of Neurology · 2022 · 25 citations · Full text

Medicine, Neurology, Pharmacotherapy +16

Effectiveness, Safety, and Tolerability of Nabiximols Oromucosal Spray vs Typical Oral Long-Acting Opioid Analgesics in Patients with Severe Neuropathic Back Pain: Analysis of 6-Month Real-World Data from the German Pain e-Registry

Michael A. Ueberall, Carlos Vila Silván, Ute Essner et al. · Pain Medicine · 2021 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17